Randomized controlled trial to evaluate the effects of ethyl-2-cyanoacrylate on pain intensity and quality of life in head and neck cancer patients suffering from cetuximab-induced rhagades during radioimmunotherapy: the support trial

BACKGROUND: Cetuximab is a chimeric monoclonal antibody against the epidermal growth factor receptor (EGFR). Skin reactions are the most common side effects of cetuximab. Rhagades of the tips of the fingers and toes, the heels and especially the interphalangeal joints are one of the most frightening...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Potthoff, Karin, Habl, Gregor, Bruckner, Thomas, Suppan, Christian, Hassel, Jessica, Jäger, Dirk, Indorf, Martin, Debus, Juergen
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2014
Sujets:
Study Protocol
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4051406/
https://ncbi.nlm.nih.gov/pubmed/24742019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-270
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires